LTBK-05. CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA PATIENTS Article

Arrillaga-Romany, Isabel, Kurz, Sylvia, Tarapore, Rohinton et al. (2021). LTBK-05. CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA PATIENTS . NEURO-ONCOLOGY, 23(Supplement_6), vi230-vi230. 10.1093/neuonc/noab196.925

cited authors

  • Arrillaga-Romany, Isabel; Kurz, Sylvia; Tarapore, Rohinton; Lu, Guangrong; Sumrall, Ashley; Butowski, Nicholas; Harrison, Rebecca; DeGroot, John; Chi, Andrew; Shonka, Nicole; Umemura, Yoshie; Odia, Yazmin; Mehta, Minesh; Nghiemphu, Phioanh; Cloughesy, Timothy; Taylor, Lynne; Graber, Jerome; Kilburn, Lindsay; Dixit, Karan; Chen, Clark; Gardner, Sharon; Aguilera, Dolly; MacDonald, Tobey; Cluster, Andrew; Mehta, Kathan; Kheradpour, Albert; Melemed, Allen; Allen, Joshua; Batchelor, Tracy; Lassman, Andrew; Wen, Patrick

authors

publication date

  • November 19, 2021

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Disorders
  • Cancer
  • Clinical Research

Digital Object Identifier (DOI)

start page

  • vi230

end page

  • vi230

volume

  • 23

issue

  • Supplement_6